Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with Venous Thromboembolism: Results of a randomized trial (SELECT-D)

Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with Venous Thromboembolism: Results of a randomized trial (SELECT-D)

<strong>Purpose</strong> Venous thromboembolism (VTE) is common in patients with cancer. Long-term daily subcutaneous low molecular weight heparin has been standard treatment for such patients. The purpose of this study was to assess if an oral factor Xa inhibitor, rivaroxaban, would off...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Young, A, Marshall, A, Thirlwall, J, Chapman, O, Lokare, A, Hill, C, Hale, D, Dunn, J, Lyman, G, Hutchinson, C, MacCallum, P, Kakkar, A, Hobbs, F, Petrou, S, Dale, J, Poole, C, Maraveyas, A, Levine, M
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: American Society of Clinical Oncology 2018

Những quyển sách tương tự